Sunlink Health Systems Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Sunlink Health Systems Inc in the third quarter 2025?
Sunlink Health Systems Inc achieved a return on average equity (ROE) of 11.72 % in its third quarter 2025, this is above SSY's average return on equity of 1.67%.
Sunlink Health Systems Inc shareholder's equity over the 12 months ending in its third quarter 2025 are valued at $15 million

ROE has advanced compared to 7.01% in the second quarter 2025, due to net income growth.

Within the Healthcare Facilities industry 13 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2025 from 697 to 1153.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2025) III. Quarter	(Dec 31 2024) II. Quarter	(Sep 30 2024) I. Quarter	(Jun 30 2024) IV. Quarter	(Mar 31 2024) III. Quarter
Y / Y Equity Change	15.52 %	8.28 %	-4.07 %	-8.29 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	2	1	-1	-2	-7
Return On Equity (TTM)	11.72 %	7.01 %	-5.23 %	-10.78 %	-49.85 %
SSY's Total Ranking	# 1153	# 697	# 2007	# 2452	# 0
Equity (TTM) in Millions	13	14	15	16	12
Seq. Equity Change	-4.77 %	-8.71 %	-3.44 %	37.6 %	-10.74 %
Seq. Net Income Change	-	-	-	-	-

Back to SSY Management Effectiveness >> SSY's 5 Years Annual ROE >> Compare SSY ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 14
Sector	# 104
Overall	# 1153

Return On Equity Statistics
High	Average	Low
98.04 %	1.67 %	-91.82 %
(Dec 31 2020)		(Jun 30 2016)

SSY Annual Return On Equity	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022	(Jun 30 2021) 2021	(Jun 30 2020) 2020
Total Equity in Millions	16	17	15	17	22
Y / Y Equity Change	-8.29 %	15.78 %	-12.47 %	-20.78 %	11.31 %
Net Income in Millions	-2	-2	-2	7	-1
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-9.56 %	-10.31 %	-13.36 %	40.09 %	-5.26 %

Back to SSY Management Effectiveness >> SSY's 5 Years Annual ROE >> Compare SSY ROE to its Competitors

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SSY's' Return on Equity at Yahoo Finance
SSY's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SSY's Competitors
Subscribers only: Roe for Sunlink Health Systems Inc 's Suppliers
Subscribers only: Return On Equity for SSY's Customers

Companies with similar Return On Equity at Mar 31 2025, within Healthcare Sector	ROE
Lifevantage Corp	32.20 %
Bristol myers Squibb Company	31.93 %
Gilead Sciences Inc	31.85 %
Nutriband Inc	30.78 %
Abbott Laboratories	30.59 %
Concentra Group Holdings Parent Inc	30.50 %
Johnson and Johnson	29.95 %
X4 Pharmaceuticals Inc	29.32 %
Pro dex Inc	29.30 %
Prestige Consumer Healthcare Inc	28.91 %
Biomx Inc	28.29 %
Catalyst Pharmaceuticals Inc	28.28 %
Ge Healthcare Technologies Inc	26.61 %
Whitehawk Therapeutics Inc	26.18 %
Chemed Corporation	26.03 %
Msa Safety Inc	25.67 %
Resmed Inc	25.66 %
Alkermes Plc	25.41 %
Siga Technologies Inc	25.24 %
Dexcom Inc	24.38 %
Harmony Biosciences Holdings inc	24.29 %
Encompass Health Corporation	24.18 %
Iradimed Corporation	23.28 %
Lantheus Holdings Inc	22.82 %
Ardent Health Inc	22.23 %
Transmedics Group Inc	21.88 %
Mimedx Group Inc	21.58 %
Iqvia Holdings Inc	20.74 %
Corcept Therapeutics Inc	20.40 %
Kewaunee Scientific Corporation	19.63 %

Date modified: 2026-09-08T15:11:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.